[V22-06] Evidence search for the S3 guideline on diagnosis and treatment of gout
Last updated 15.11.2023
Project no.:
V22-06
Commission:
Commission awarded on 20.12.2022 by the Federal Ministry of Health (BMG).
Report type:
Evidence search
Status:
Commission completed
Department/Division:
Health Care and Guidelines
Topic:
DMP and clinical pratice guidelines
The search for evidence on the S3 guideline on guideline on diagnosis and treatment of gout covers 6 evidence reports.
https://dx.doi.org/10.60584/V22-06A: Evidence report for the S3 guideline on diagnosis and treatment of gout: Test accuracy of various methods for diagnosing gout (V22-06A)
https://dx.doi.org/10.60584/V22-06B: Evidence report for the S3 guideline on diagnosis and treatment of gout: Drug treatment of a gout attack (V22-06B)
https://dx.doi.org/10.60584/V22-06C: Evidence report for the S3 guideline on diagnosis and treatment of gout: Xanthine oxidase inhibitors (V22-06C)
https://dx.doi.org/10.60584/V22-06D: Evidence report for the S3 guideline on diagnosis and treatment of gout: Allopurinol versus febuxostat (V22-06D)
https://dx.doi.org/10.60584/V22-06E: Evidence report for the S3 guideline on diagnosis and treatment of gout: Treatment of comorbidities (V22-06E)
https://dx.doi.org/10.60584/V22-06F: Evidence report for the S3 guideline on diagnosis and treatment of gout: Lifestyle changes for gout (V22-06F)